All four H2020 projects involve ICT-enabled health solutions, from patient empowerment (ProEmpower) to cross-border eHealth standards (UNICOM).
AZIENDA OSPEDALIERA UNIVERSITARIA FEDERICO II
Naples university hospital specialising in digital health deployment, chronic disease monitoring, and EU medicine identification standards.
Their core work
AOU Federico II is the university hospital of the University of Naples Federico II, one of Italy's oldest and largest academic medical centers. In H2020, they focused on digital health innovation — particularly ICT-enabled patient monitoring, self-management tools for chronic diseases like diabetes and hypertension, and the EU-wide standardisation of medicine identification systems. Their role bridges clinical practice with digital health deployment, testing and validating eHealth solutions in a real hospital environment serving the Naples metropolitan area.
What they specialise in
ProEmpower targeted type 2 diabetes self-management; HSMonitor focused on ICT-enabled hypertension monitoring and health optimisation.
UNICOM addresses global univocal identification of medicines using IDMP standards, involving EMA coordination and cross-border eHealth networks.
WE4AHA supported large-scale uptake of digital innovation for active and healthy ageing across Europe.
How they've shifted over time
Their earlier projects (2016-2017) focused broadly on digital health adoption — patient empowerment for diabetes and scaling digital innovation for healthy ageing. By 2019, their focus sharpened toward more specific and technically demanding topics: ICT-based hypertension monitoring through pre-commercial procurement and EU-wide drug identification standardisation (IDMP/UNICOM). The trajectory shows a shift from general eHealth uptake toward specialised clinical digital systems and regulatory-grade data standards.
Moving toward structured health data interoperability and standards-based digital infrastructure, making them a relevant partner for projects involving EU-wide health data spaces or cross-border pharmaceutical systems.
How they like to work
AOU Federico II operates exclusively as a participant — they have not coordinated any H2020 projects. They contribute clinical expertise and real-world hospital environments for validation rather than leading consortium management. With 59 unique partners across 20 countries, they are well-connected across Europe and comfortable working in large, multi-national consortia.
Despite only four projects, they have built a broad network of 59 partners across 20 countries, indicating participation in large consortia with wide European reach. Their network spans clinical, digital, and public health sectors across Southern, Western, and Northern Europe.
What sets them apart
As a major university hospital in Naples, AOU Federico II offers something many digital health projects need but struggle to find: a large-scale clinical environment willing to pilot and validate eHealth solutions with real patients. Their involvement in both pre-commercial procurement (PCP) projects and standards-setting initiatives (UNICOM) means they understand both the innovation procurement process and regulatory requirements. For consortium builders, they bring clinical credibility plus experience deploying digital tools in a Southern European healthcare context — a region often underrepresented in eHealth pilots.
Highlights from their portfolio
- UNICOMLargest project by funding (EUR 310,000), tackling the global challenge of univocal medicine identification — directly relevant to EU pharmaceutical regulation and cross-border healthcare.
- HSMonitorPre-commercial procurement project for hypertension monitoring, representing AOU Federico II's role as a demanding buyer of innovative ICT health solutions rather than just a technology tester.